Yonghe Intelligent Control announced that its wholly-owned subsidiary Chengdu Yonghecheng plans to transfer 100% of its wholly-owned subsidiary Kunming Medical. From November 24, 2025 to January 2026, the company was listed and transferred four times, all to no avail. During the fourth listing announcement period, one intended transferee, Yunnan Renxin, was collected and qualified for the transfer after review. In 2026, the two sides signed an agreement. Chengdu Yonghecheng transferred shares at a transaction price of 16.683 million yuan, including 4.683 million yuan in cash, and Yunnan Renxin assumed 12 million yuan of debt. The deal is aimed at optimizing the industrial structure, and no significant adverse effects are expected.

Yonghe Intelligent Control announced that its wholly-owned subsidiary Chengdu Yonghecheng plans to transfer 100% of its wholly-owned subsidiary Kunming Medical. From November 24, 2025 to January 2026, the company was listed and transferred four times, all to no avail. During the fourth listing announcement period, one intended transferee, Yunnan Renxin, was collected and qualified for the transfer after review. In 2026, the two sides signed an agreement. Chengdu Yonghecheng transferred shares at a transaction price of 16.683 million yuan, including 4.683 million yuan in cash, and Yunnan Renxin assumed 12 million yuan of debt. The deal is aimed at optimizing the industrial structure, and no significant adverse effects are expected.